Heparin-induced thrombocytopenia: Pathophysiology and clinical concerns

Bailliere's Clinical Haematology

Volumn 11, Issue 2, 1998, Pages 461-474

  Greinacher, A ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

Heparin; Heparin induced thrombocytopenia; PF4; Platelets

Indexed keywords

ANTICOAGULANT AGENT; DANAPAROID; HEPARIN; LEPIRUDIN; THROMBIN;

CLINICAL ARTICLE; CLINICAL FEATURE; HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 0032428962     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(98)80061-9     Document Type: Article

References (74)

1. Amiral J Bridey F Dreyfus M Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia (letter) Thrombosis and Haemostasis 68 1992 95 96
2. Amiral J Bridey F Wolf M Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases Thrombosis and Haemostasis 73 1995 21 28
3. Amiral J Marfaing-Koka A Wolf M Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia Blood 88 1996 410 416
4. Arepally G McKenzie SE Jiang XM FcγRIIA H/R 131 polymorphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis Blood 89 1997 370 375
5. Arnout J The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelism with heparin-induced thrombocytopenia Thrombosis and Haemostasis 75 1996 536 541
6. (supplement) P 2305 Bachelot-Loza C Saffroy R Lasne D Role of FcγRIIa-Arg/His-131 polymorphism in HIT diagnosis Thrombosis and Haemostasis 1997
7. Bauer TL Arepally G Konkle BA Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery Circulation 95 1997 1242 1246
8. 506-Gln mutation in factor V and risk of thrombosis during pregnancy British Journal of Haematology 92 1996 473 478
9. Bouvier JL Lefebre P Villain P Treatment of serious heparin-induced thrombocytopenia by plasma exchange: report on 4 cases Thrombosis Research 51 1988 335 336
10. Brace LD Fareed J Heparin-induced platelet aggregation. II. Dose/response relationships for two low molecular weight heparin fractions (CY 216 and CY 222) Thrombosis Research 59 1990 1 14
11. Brandt JT Isenhart CE Osborne JM On the role of platelet FcγRIIa phenotype in heparin-induced thrombocytopenia Thrombosis and Haemostasis 74 1995 1564 1572
12. Burgess JK Chong BH The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controls European Journal of Haematology 58 1997 279 285
13. Burgess JK Lindeman R Chesterman CN Chong BH Single amino acid mutation of Fcγ receptor is associated with the development of heparin-induced thrombocytopenia British Journal of Haematology 91 1995 761 766
14. Carlsson LE Santoso S Baurichter G Heparin-induced thrombocytopenia: new insights into the impact of the FcγRIIa-R-H131 polymorphism Blood 92 1998 1 7
15. Chong BH Ismail F The mechanism of heparin-induced platelet aggregation European Journal of Haematology 43 1989 245 251
16. Chong BH Ismail F Cade J Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172 Blood 73 1989 1592 1596
17. Chong BH Fawaz I Chesterman CN Berndt MC Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets British Journal of Haematology 73 1989 235 240
18. Chong BH Murray B Berndt MC Plasma P-selectin is increased in thrombotic consumptive platelet disorders Blood 83 1994 1535 1541
19. Cines DB Tomaski A Tannenbaum S Immune endothelial-cell injury in heparin-associated thrombocytopenia New England Journal of Medicine 316 1987 581 589
20. Cohen JI Cooper MR Greenberg CS Streptokinase therapy of pulmonary emboli with heparin-associated thrombocytopenia Archives of Internal Medicine 145 1985 1725 1726
21. Danhof M de Boer A Magnani HN Stiekema JC Pharmacokinetic considerations of Orgaran (Org 10172) therapy Haemostasis 22 1992 73 84
22. Demers C Ginsberg JS Brill-Edwars P Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia Blood 78 1991 2194 2197
23. 131) gene in patients with heparin-induced thrombocytopenia Journal of Laboratory Clinical Medicine 130 1997 278 284
24. Doherty DC Ortel TL De Bruijn N ‘Heparin-free’ cardiopulmonary bypass: first reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass Anaesthesiology 73 1990 562 565
25. (supplement) Eichler P Olbrich K Pötzsch B Greinacher A Anti-hirudin antibodies in patients treated with recombinant hirudin for more than five days, a prospective study (abstract) Thrombosis and Haemostasis 1997 PS2014
26. Fiessinger JN Aiach M Roncato M Critical ischemia during heparin-induced thrombocytopenia. Treatment by intra-arterial streptokinase Thrombosis Research 33 1984 235
27. Frame JN Mulvey KP Phares JC Correction of severe heparin-associated thrombocytopenia with intravenous immunoglobulin Annals of Internal Medicine 111 1989 946 947
28. Gardyn J Sorkyn P Kluger Y Heparin-induced thrombocytopenia and fatal thrombosis in a patient with activated protein C resistance American Journal of Hematology 50 1995 292 295
29. Greinacher A Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesis Seminars Thrombosis and Haemostasis 21 1995 106 116
30. Greinacher A Michels I Mueller-Eckhardt C Heparin-associated thrombocytopenia: the antibody is not heparin specific Thrombosis and Haemostasis 67 1992 545 549
31. Greinacher A Michels I Kiefel V Mueller-Eckhardt C A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia Thrombosis and Haemostasis 66 1991 734 736
32. Greinacher A Völpel H Pötzsch B Recombinant hirudin in the treatment of patients with heparin-induced thrombocytopenia Blood 88 supplement 1 1996 1113
33. Greinacher A Zinn S Wizeman U Birk B Heparin-induced antibodies as a risk factor for thromboembolism and haemorrhage in patients undergoing chronic haemodialysis Lancet 348 1996 764
34. Greinacher A Liebenhoff U Kiefel V Heparin-associated thrombocytopenia: the effects of various intravenous IgG preparations on antibody mediated platelet activation—a possible new indication for high dose i.v. IgG Thrombosis and Haemostasis 71 1994 641 645
35. Greinacher A Amiral J Dummel V Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4-heparin enzyme linked immunosorbent assay Transfusion 34 1994 381 385
36. Greinacher A Pötzsch B Amiral J Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen Thrombosis and Hemostasis 71 1994 247 251
37. Greinacher A Alban S Dummel V Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia Thrombosis and Haemostasis 74 1995 886 892
38. Hach-Wunderle V Kainer K Salzmann G Müller-Berghaus G Heparin-related thrombosis despite normal platelet counts in vascular surgery American Journal of Surgery 173 1997 117 119
39. Horne MDK III The effect of secreted heparin-binding proteins on heparin binding to platelets Thrombosis Research 70 1993 91 98
40. Jason PA Moake JL Carpinito G Aspirin prevents heparin-induced platelet aggregation in vivo (letters) British Journal of Haematology 53 1983 166 168
41. Kappers-Klunne MC Boon DMS Hop WCJ Heparin-induced thrombocytopenia and thrombosis: a prospective analysis of the incidence in patients with heart and cerebrovascular diseases British Journal of Haematology 96 1997 442 446
42. Kelton JG Sheridan D Santos A Heparin-induced thrombocytopenia Blood 72 1988 925 930
43. Koeleman BPC Reitsma PH Allaart CF Bertina RM Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families Blood 84 1994 1031 1035
44. Lerou J Leclerc MH Delahousse B Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY 216) Seminars in Thrombosis and Haemostasis 11 1985 326 329
45. Magnani HN Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (Org 10172) Thrombosis and Haemostasis 70 1993 554 561
46. Magnani HN Orgaran (danaparoid-sodium) use in the syndrome of heparin-induced thrombocytopenia Proceedings of a workshop held in London 1996 Nov 1 Platelets 8 1997 74 81
47. Magnani HN Beijering RJR Ten Cate JW Orgaran anticoagulation for cardiopulmonary bypass in patients with heparin-induced thrombocytopenia Roque Pifarré New Anticoagulants for the Cardiovascular Patient 1997 Hanley & Belfus Philadelphia 487 500
48. Malia RG Kitchen S Greaves M Preston FE Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies British Journal of Haematology 76 1990 101 107
49. Marciniak E Romond EH Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant Blood 74 1989 2426 2432
50. Meuleman DG Orgaran (Org 10172): its pharmacological profile in experimental models Haemostasis 22 1992 58 65
51. Mikhailidis DP Barradas MA Jeremy JY Heparin-induced platelet aggregation in anorexia nervosa and in severe peripheral vascular disease European Journal of Clinical Investigation 15 1985 313 319
52. Nurden AT Laroche-Traineau J Jallu V Heparin-induced thrombocytopenia: observations on the nature of the antibody activities and on the use of gammaglobulin concentrates in a patient with thrombotic complications (abstract) Thrombosis and Haemostasis 65 1991 796
53. Ortel TL Gockerman JP Califf RM Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin-induced thrombocytopenia and thrombosis Thrombosis and Haemostasis 67 1992 292 296
54. Papenberg S Carlsson LE Eichler P Heterozygosity for factor V leiden is not the major for thromboembolic complications in patients with heparin-induced thrombocytopenia (abstract) Annals of Hematology 76 1998 A59
55. Polgar J Eichler P Greinacher A Clemetson KJ Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients Blood 91 1998 549 554
56. Pötzsch B Madlener K Seelig C The whole blood ecarin clotting time assay allows rapid and accurate monitoring of the anticoagulant response of r-hirudin during cardiopulmonary bypass Thrombosis and Haemostasis 77 1997 920 925
57. Reininger CB Greinacher A Graf J Platelets of patients with peripheral arterial disease are hypersensitive to heparin Thrombosis Research 81 1996 641 649
58. Salzman EW Rosenberg RD Smith MH Lindon JN Effect of heparin and heparin fractions on platelet aggregation Journal of Clinical Investigation 65 1980 64 73
59. Schiele F Vuillemenot A Kramarz P Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia American Journal of Hematology 50 1995 20 25
60. Sheridan D Carter C Kelton JG A diagnostic test for heparin-induced thrombocytopenia Blood 67 1986 27 30
61. Simantov R Lo SK Salmon JE Factor V Leiden increases the risk of thrombosis in patients with antiphospholipid antibodies Thrombosis Research 84 1996 361 365
62. Suh JS Mohammad IM Aster RH Visentin GP Characterization of the humoral immune response in heparin-induced thrombocytopenia American Journal of Hematology 54 1997 196 201
63. Vandenbroucke JP Koster T Briet E Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation Lancet 344 1994 1453 1457
64. Visentin GP Ford SE Scott JP Aster RH Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells Journal of Clinical Investigation 93 1994 81 88
65. Visentin GP Malik M Cyganiak KA Aster RH Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin-platelet factor 4 complexes Journal of Laboratory Clinical Medicine 128 1996 376 383
66. Warkentin TE Heparin-induced skin lesions British Journal of Haematology 92 1996 494 497
67. Warkentin TE Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia Transfusion Medicine Review 10 1996 249 258
68. Warkentin TE Kelton JG Interaction of heparin with platelets, including heparin-induced thrombocytopenia Bounameaux H Low-Molecular-Weight Heparins in Prophylaxis and Therapy of Thromboembolic Diseases 1994 Marcel Dekker Inc. New York 75 127
69. Warkentin TE Kelton JG A 14-years study of heparin-induced thrombocytopenia American Journal of Medicine 101 1996 502 507
70. Warkentin TE Chong BH Greinacher A Heparin-induced thrombocytopenia: towards consensus Thrombosis and Haemostasis 79 1998 1 7
71. Warkentin TE Hayward CPM Boshkov LK Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia Blood 84 1994 3691 3699
72. Warkentin TE Levine MN Hirsh J Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin New England Journal of Medicine 332 1995 1330 1335
73. Warkentin TE Elavathil LJ Hayward CPM The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia Annals of Internal Medicine 127 1997 804 812
74. Wilde MI Markham A Danaparoid: a review of its pharmacology and clinical use in the management of Heparin-induced thrombocytopenia Drugs 54 1997 903 924